PRV Watch @PRVWatch

Tracking FDA Priority Review Voucher (PRV) issuances, sales, redemptions and other FDA/Biotech news. prvwatch.com Joined January 2025

Tweets

411
Followers

589
Following

68
Likes

51

PRV Watch @PRVWatch

16 hours ago

7 Priority Review Voucher sales announced so far this year with the smaller biotechs opting to monetize their PRVs as soon as possible from it being issued. Prices between $180M - $200M holding strong.

0 7 10 3K 10

View Details

PRV Watch @PRVWatch

7 days ago

This is the most Priority Review Voucher transaction activity in a single quarter EVER.

0 0 9 2K 2

View Details

PRV Watch @PRVWatch

7 days ago

Denali Therapeutics $DNLI announced today that they have sold the priority review voucher they were issued in March for $195M . Six of the Seven PRVs issued this year have been sold already, with the last to be likely retained by the company (Regeneron) to redeem themselves.

1 1 8 4K 6

View Details

PRV Watch @PRVWatch

a week ago

@AlecGaffney Congrats Alec 😊

0 0 1 111 0

View Details

PRV Watch @PRVWatch

2 weeks ago

Anyone with expertise relating to HSR Act early termination notices. Seeking some advice/info. DM

0 0 0 227 0

View Details

PRV Watch @PRVWatch

2 weeks ago

Sanofi $SNY receives approval for Tzield (teplizumab) to treat pediatric stage 3 T1D. Sanofi was awarded a Commissioner's National Priority Voucher for this indication but its unclear if this approval was still under the CNPV program as the decision has been delayed for months.

0 1 1 553 1

View Details

Ethan Perlstein 1-to-N @eperlste

2 weeks ago

most people in biotech don't even know the PRV exists, but the data are there for anyone who's curious 📊👀 at the current clearing price of ~$200M, it now pays to invest in rare disease drug development the demand for PRVs is going up because pharma is hungry for blockbusters

1 4 17 3K 3

View Details

PRV Watch @PRVWatch

2 weeks ago

@ryan_1000cures @1000cures Thanks Ryan, appreciate the support 🙏🏼

0 0 2 28 0

View Details

PRV Watch @PRVWatch

2 weeks ago

Recently launched the new PRV Watch website tracking the world of FDA Priority Review Vouchers. Check it out: prvwatch.com

2 1 11 566 1

View Details

PRV Watch @PRVWatch

2 weeks ago

Built by Christina @Suupercharged

0 0 2 318 0

View Details

PRV Watch @PRVWatch

3 weeks ago

Commissioner’s National Priority Voucher public hearing underway. Spokesperson from @PhRMA asked in their statement to change the name to remove ‘voucher’ as it isn’t a tradable asset like the other voucher programs. I endorse this suggestion, I would make it a ‘designation’.

0 0 8 460 0

View Details

PRV Watch @PRVWatch

3 weeks ago

In NYC next week if anyone is about. DM

0 0 0 221 0

View Details

PRV Watch @PRVWatch

4 weeks ago

It’s been a very active Q2 so far for Priority Review Voucher sales

0 3 8 1K 1

View Details

PRV Watch @PRVWatch

a month ago

The Commissioner’s National Priority Voucher program has dramatically reduced FDA timelines for the two novel drugs approved within the program so far. - Foundayo, an oral GLP-1 approved ~2.5 months after submission. - Otarmeni, a gene therapy for genetic hearing loss approved ~4 months after submission.

1 2 10 4K 2

View Details

PRV Watch @PRVWatch

a month ago

$LLY Eli Lilly had planned to use a Priority Review Voucher (current value $200M) for its oral GLP-1 Foundayo to speed up FDA review. However, they were granted a Commissioner’s National Priority Voucher, enabling a faster approval while preserving its PRV for a future use.

1 1 6 855 2

View Details

PRV Watch @PRVWatch

a month ago

7 Priority Review Vouchers have been issued so far in 2026 and 5 of them have already been sold.

2 1 6 2K 3

View Details

PRV Watch @PRVWatch

a month ago

@prosperousguy Not disclosed

0 0 1 105 0

View Details

PRV Watch @PRVWatch

a month ago

Immedica Pharma announced today that it has sold the priority review voucher they received in Feb for $200M . the PRV market is hot 🔥

PRV Watch @PRVWatch

2 months ago

In the last 10 days there have been three Priority Review Voucher sales disclosed .... $180M, $195M and $187.5M

0 1 11 10K 3

1 5 24 15K 5

View Details

PRV Watch @PRVWatch

a month ago

Foundayo (orforglipron) was the first novel drug approved under the Commissioner's National Priority Voucher pilot program. The FDA review documents hadn't been published for a while but are now available. accessdata.fda.gov/drugsatfda_doc…

0 0 8 2K 5

View Details

PRV Watch @PRVWatch

a month ago

Marty Makary introduced the Commissioner's National Priority Voucher pilot program last year with 22 vouchers issued and 7 approvals under the program so far. Will the next FDA Commissioner continue to issue Commissioner National Priority Vouchers?